| A2AP | alpha 2-antiplasmin |
| ACS | acute coronary syndrome |
| CAD | coronary artery disease |
| FXIII/FXIIIa | coagulation factor XIII/activated coagulation factor XIII |
| GTT | Global Thrombosis Test |
| MACE | major cardiovascular adverse events |
| MI | myocardial infarction |
| PAI-1/-2 | Plasminogen activator inhibitor-1/-2 |
| ROTEM | Thromboelastometry |
| TAFI | Thrombin activatable fibrinolysis inhibitor |
| TEG | Thromboelastography |
| VTE | venous thromboembolism |